Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Atrial Fibrillation

rosiglitazone has been researched along with Atrial Fibrillation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korantzopoulos, P; Li, G; Li, J; Liu, T; Zhao, H1
Kokkoris, S; Korantzopoulos, P; Kountouris, E; Melidonis, A; Protopsaltis, I; Siogas, K1
Achtari Jeanneret, L; Barras-Moret, AC; Carron, P; Deriaz-Chessex, S; Donzé, J; Fournier, Y; Gachoud, D; Moix, PA; Monti, M; Rossier, A; Wilson, P1

Other Studies

3 other study(ies) available for rosiglitazone and Atrial Fibrillation

ArticleYear
Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits.
    Cardiovascular therapeutics, 2014, Volume: 32, Issue:4

    Topics: Alloxan; Animals; Atrial Fibrillation; Atrial Function, Left; Atrial Remodeling; Biomarkers; Cardiac Pacing, Artificial; Diabetes Mellitus, Experimental; Fibrosis; Heart Atria; Hypoglycemic Agents; Inflammation Mediators; Oxidative Stress; Rabbits; Rosiglitazone; Thiazolidinediones; Time Factors

2014
Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy.
    International journal of cardiology, 2008, Apr-25, Volume: 125, Issue:3

    Topics: Atrial Fibrillation; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Rosiglitazone; Thiazolidinediones

2008
[Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents].
    Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142

    Topics: Accidental Falls; Aged; Albuterol; Anemia; Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Atrial Fibrillation; Attitude of Health Personnel; Benzazepines; Bronchitis, Chronic; Bronchodilator Agents; Cardiac Pacing, Artificial; Diabetes Mellitus; Endocarditis, Bacterial; Erythropoietin; Heart Failure; Heparin; Humans; Internal Medicine; Interprofessional Relations; Medical Staff, Hospital; Myocardial Infarction; Recombinant Proteins; Risk Management; Rosiglitazone; Salmeterol Xinafoate; Thiazolidinediones; Thromboembolism; Tolvaptan; Vasodilator Agents; Ventricular Dysfunction, Left; Workload

2008